SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFocusrite Regulatory News (TUNE)

Share Price Information for Focusrite (TUNE)

Share Price is delayed by 15 minutes
Get Live Data
195.00    10.00 (5.41%)
Bid:
190.00
Ask:
200.00
Spread: 10.00 (5.263%)
Market Cap: £113.24m
TUNE Live PriceLast checked at - London Stock Exchange

Intraday Focusrite Share Chart

PDMR Dealings

25 Nov 2021 14:37

RNS Number : 6375T
Focusrite PLC
25 November 2021
Β 

Focusrite plc

Β 

("the Company" or "the Group")

Β PDMR Dealings

Settlement of Share Options

Β 

Focusrite plc (AIM:TUNE), the global music and audio products company that trades under the Focusrite and Novation brands,Β announces that on 23 November 2021 Tim Carroll, Damian Hawley and Simon Holt, each being a Person Discharging Managerial Responsibilities ("PDMRs"), exercised nominal cost options over 81,782 shares granted to them under the Company's Performance Share Plan and acquired ordinary shares of 0.1p each in the Company.

Β 

The option was granted on 21 November 2018 and became vested and exercisable as from 22 November 2021.

Β 

The exercise of the option was settled in part by the transfer of 43,345 ordinary shares and in part with a cash payment equal to market value of 38,437 ordinary shares to meet the PDMRs' liability to income tax and employee national insurance arising on the exercise of the option.

Β 

Following the transaction:

Mr. Carroll will have a beneficial holding of 78,741 Ordinary Shares which represents 0.13% of the current issued share capital.

Mr. Hawley will have a beneficial holding of 177,852 Ordinary Shares which represents 0.30% of the current issued share capital.

Mr. Holt will have a beneficial holding of 144,056 Ordinary Shares which represents 0.25% of the current issued share capital.

Β 

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

1

DetailsΒ of the persons discharging managerial responsibilitiesΒ IΒ person closelyΒ associated

a)

Name

Β Tim Carroll

2

ReasonΒ forΒ theΒ notification

a)

Position/status

Β CEO

b)

InitialΒ notificationΒ /Amendment

Β Initial notification

3

Details of the issuer, emission allowance marketΒ participant,Β auction platform,Β auctioneerΒ orΒ auction monitor

a)

Name

Focusrite plc

b)

LEI

213800JJ51KA4LOTF736

4A

DetailsΒ ofΒ theΒ transaction(s):Β sectionΒ toΒ beΒ repeated forΒ (i)Β eachΒ typeΒ of instrument;Β (ii)Β eachΒ typeΒ ofΒ transaction;Β (iii)Β eachΒ date;Β andΒ (iv)Β eachΒ place whereΒ transactions haveΒ beenΒ conducted

a)

Description of the financialΒ instrument,Β typeΒ of instrument

Ordinary Shares of 0.1p each in Focusrite plc

IdentificationΒ code

GB00BSBMW716

b)

NatureΒ ofΒ theΒ transaction

Exercise of a nominal cost option under the Focusrite plc Performance Share Plan and acquisition of ordinary shares of 0.1p each in Focusrite plc (or, as to 47% of the vested shares number, cash in lieu of such shares).

c)

Price(s)Β andΒ volume(s)

Β 

Price(s)

Volumes

Β£51.72

51,722 (settled in part by the transfer of 27,413 ordinary shares and in part with a cash payment equal to market value of 24,309 ordinary shares to meet the PDMR's liability to income tax and employee national insurance arising on the exercise of the option over 51,722 shares)

Β 

d)

Aggregated information

- Aggregated volumeΒ 

- PriceΒ 

Not applicable - single transaction

e)

Date of the transaction

23 November 2021

f)

Place of the transaction

Outside a trading venue

Β 

Β 

1

DetailsΒ of the persons discharging managerial responsibilitiesΒ IΒ person closelyΒ associated

a)

Name

Β Damian Hawley

2

ReasonΒ forΒ theΒ notification

a)

Position/status

Β Chief Revenue Officer

b)

InitialΒ notificationΒ /Amendment

Β Initial notification

3

Details of the issuer, emission allowance marketΒ participant,Β auction platform,Β auctioneerΒ orΒ auction monitor

a)

Name

Focusrite plc

b)

LEI

213800JJ51KA4LOTF736

4A

DetailsΒ ofΒ theΒ transaction(s):Β sectionΒ toΒ beΒ repeated forΒ (i)Β eachΒ typeΒ of instrument;Β (ii)Β eachΒ typeΒ ofΒ transaction;Β (iii)Β eachΒ date;Β andΒ (iv)Β eachΒ place whereΒ transactions haveΒ beenΒ conducted

a)

Description of the financialΒ instrument,Β typeΒ of instrument

Ordinary Shares of 0.1p each in Focusrite plc

IdentificationΒ code

GB00BSBMW716

b)

NatureΒ ofΒ theΒ transaction

Exercise of a nominal cost option under the Focusrite plc Performance Share Plan and acquisition of ordinary shares of 0.1p each in Focusrite plc (or, as to 47% of the vested shares number, cash in lieu of such shares).

c)

Price(s)Β andΒ volume(s)

Β 

Price(s)

Volumes

Β£17.09

17,089 (settled in part by the transfer of 9,057 ordinary shares and in part with a cash payment equal to market value of 8,032 ordinary shares to meet the PDMR's liability to income tax and employee national insurance arising on the exercise of the option over 17,089 shares)

Β 

d)

Aggregated information

- Aggregated volumeΒ 

- PriceΒ 

Not applicable - single transaction

e)

Date of the transaction

23 November 2021

f)

Place of the transaction

Outside a trading venue

Β 

Β 

1

DetailsΒ of the persons discharging managerial responsibilitiesΒ IΒ person closelyΒ associated

a)

Name

Β Simon Holt

2

ReasonΒ forΒ theΒ notification

a)

Position/status

Β Engineering Director

b)

InitialΒ notificationΒ /Amendment

Β Initial notification

3

Details of the issuer, emission allowance marketΒ participant,Β auction platform,Β auctioneerΒ orΒ auction monitor

a)

Name

Focusrite plc

b)

LEI

213800JJ51KA4LOTF736

4A

DetailsΒ ofΒ theΒ transaction(s):Β sectionΒ toΒ beΒ repeated forΒ (i)Β eachΒ typeΒ of instrument;Β (ii)Β eachΒ typeΒ ofΒ transaction;Β (iii)Β eachΒ date;Β andΒ (iv)Β eachΒ place whereΒ transactions haveΒ beenΒ conducted

a)

Description of the financialΒ instrument,Β typeΒ of instrument

Ordinary Shares of 0.1p each in Focusrite plc

IdentificationΒ code

GB00BSBMW716

b)

NatureΒ ofΒ theΒ transaction

Exercise of a nominal cost option under the Focusrite plc Performance Share Plan and acquisition of ordinary shares of 0.1p each in Focusrite plc (or, as to 47% of the vested shares number, cash in lieu of such shares).

c)

Price(s)Β andΒ volume(s)

Β 

Price(s)

Volumes

Β£12.97

12, 971 (settled in part by the transfer of 6,875 ordinary shares and in part with a cash payment equal to market value of 6,096 ordinary shares to meet the PDMR's liability to income tax and employee national insurance arising on the exercise of the option over 12, 971 shares)

Β 

d)

Aggregated information

- Aggregated volumeΒ 

- PriceΒ 

Not applicable - single transaction

e)

Date of the transaction

23 November 2021

f)

Place of the transaction

Outside a trading venue

Β 

-ends-

Focusrite plc:

Tim Carroll (CEO)

+44 1494 462246

Sally McKone (CFO)

+44 1494 462246

Investec Bank plc (Nominated Adviser and Joint Broker)

+44 (0) 20 7597 5970

David Flin

William Brinkley

Charlotte Young

Peel Hunt LLP (Joint Broker)

+44 (0) 20 7418 8900

Edward Knight

Michael Burke

James Smith

Belvedere Communications

John West

+44 20 3687 2753

Llew Angus

+44 20 3687 2754

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHBSBDBSXDDGBU
Date   Source Headline
27th May 20267:00 amRNSNotice of Results
5th May 20264:25 pmRNSTR-1
8th Apr 20263:56 pmRNSTR-1
19th Mar 20267:00 amRNSTrading Update: Trading in-line with expectations
2nd Mar 20267:00 amRNSBoard Changes
24th Dec 20259:21 amRNSTR-1
24th Dec 20259:21 amRNSTR-1
24th Dec 20259:19 amRNSTransfer of shares to Trust
24th Dec 20259:19 amRNSTransfer of shares to Trust
18th Nov 202512:38 pmRNSDirector Share Dealings
4th Nov 20257:00 amRNSInterim Results
14th Oct 20257:00 amRNSNotice of Results
16th Sep 20257:00 amRNSTrading Update
7th May 20253:25 pmRNSTR-1
30th Apr 20253:41 pmRNSDividend Timetable Correction
29th Apr 20257:00 amRNSInterim Results
16th Apr 20252:38 pmRNSGrant of Share Options to PDMRs
11th Apr 20258:50 amRNSTR-1
8th Apr 20251:43 pmRNSTR-1
8th Apr 20257:00 amRNSTR-1
8th Apr 20257:00 amRNSTR-1
3rd Apr 20257:00 amRNSNotice of Interim Results
26th Mar 20253:16 pmRNSTR-1
20th Mar 20257:00 amRNSTrading Update
19th Mar 20258:13 amRNSTR-1
4th Mar 20252:46 pmRNSTR-1
31st Jan 202512:29 pmRNSResult of AGM
31st Jan 20257:00 amRNSAGM Statement and Trading Update
11th Dec 20247:00 amRNSTR-1
5th Dec 20243:38 pmRNSDirector Share Dealings
5th Dec 20243:37 pmRNSGrant of Share Options to PDMRs
5th Dec 20247:00 amRNSTR1
27th Nov 20247:00 amRNSFinal Results for the Year Ended 31 Aug 2024
30th Oct 20247:00 amRNSNotice: Final Results, Change of Year End, Auditor
28th Aug 20247:00 amRNSTrading Statement
1st Aug 20247:00 amRNSTR-1
15th Jul 20244:17 pmRNSTR-1
25th Apr 20247:00 amRNSInterim Results
22nd Apr 20246:09 pmRNSTR-1
9th Apr 20247:00 amRNSInvestor Presentation via Investor Meet Company
8th Apr 20247:00 amRNSNotice of Interim Results
22nd Mar 20243:36 pmRNSNotification of PDMR Transactions
22nd Mar 20248:01 amRNSTR-1
20th Mar 20247:01 amRNSTR-1
19th Mar 20244:44 pmRNSNotification of PDMR Transactions
18th Mar 20247:00 amRNSTrading Update
14th Feb 20243:10 pmRNSNotification of PDMR Transactions
7th Feb 20242:25 pmRNSTR-1
19th Jan 202412:59 pmRNSResult of AGM
19th Jan 20247:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.